Inhibition of Metabolic Shift can Decrease Therapy Resistance in Human High-Grade Glioma Cells

The high-grade brain malignancy, glioblastoma multiforme (GBM), is one of the most aggressive tumours in central nervous system. The developing resistance against recent therapies and the recurrence rate of GBMs are extremely high. In spite several new ongoing trials, GBM therapies could not signifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Petővári, Gábor, Dankó, Titanilla, Krencz, Ildikó, Hujber, Zoltán, Rajnai, Hajnalka, Vetlényi, Enikő, Raffay, Regina, Pápay, Judit, Jeney, András, Sebestyén, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7109188/
https://www.ncbi.nlm.nih.gov/pubmed/31187466
http://dx.doi.org/10.1007/s12253-019-00677-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7109188/
https://www.ncbi.nlm.nih.gov/pubmed/31187466
http://dx.doi.org/10.1007/s12253-019-00677-2

Ejemplares similares